1. Home
  2. CWT vs TRVI Comparison

CWT vs TRVI Comparison

Compare CWT & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Water Service Group

CWT

California Water Service Group

HOLD

Current Price

$49.42

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$18.34

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWT
TRVI
Founded
1926
2011
Country
United States
United States
Employees
1105
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
CWT
TRVI
Price
$49.42
$18.34
Analyst Decision
Buy
Strong Buy
Analyst Count
1
11
Target Price
$55.00
$21.55
AVG Volume (30 Days)
444.2K
2.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
2.95%
N/A
EPS Growth
N/A
31.91
EPS
1.01
N/A
Revenue
$963,695,000.00
N/A
Revenue This Year
$10.18
N/A
Revenue Next Year
$5.81
N/A
P/E Ratio
$48.94
N/A
Revenue Growth
6.41
N/A
52 Week Low
$41.29
$6.93
52 Week High
$53.82
$20.22

Technical Indicators

Market Signals
Indicator
CWT
TRVI
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CWT
TRVI

About CWT California Water Service Group

California Water Service Group is a U.S. water and utilities holding company based in California. The company provides water utility and other related services in California, Washington, New Mexico, Hawaii and Texas through its wholly-owned subsidiaries. The bulk of the company's business consists of the production, purchase, storage, treatment, testing, distribution, and sale of water for domestic, industrial, public, and irrigation uses, and the provision of water for domestic and municipal fire protection services.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: